September 10, 2020
RegeNephron, a spinout of Kyoto University’s Center for iPS Cell Research and Application (CiRA), said on September 9 that it has sealed a collaborative research accord with Kirin Holdings for process development related to cell therapies using nephron progenitor cells...read more